Getting Weight Loss Injections Online Safely
How to get weight loss injections such as Mounjaro or Wegovy online safely in the UK: legal routes, registration checks, warning signs and safe home use.
On this page
You can get weight loss injections such as Mounjaro (tirzepatide) and Wegovy (semaglutide) online safely and legally in the UK, but only through a registered prescriber and a registered pharmacy, after a genuine medical assessment. The safe route has three parts: a regulated service (checked on the official registers), a proper consultation that verifies your identity, weight and medical history, and licensed medicine from the legitimate supply chain with clear aftercare. Anything that skips one of these, such as injections sold on social media or "no consultation needed" websites, is neither legal nor safe. This guide explains each step. It is part of our safety guides, within our wider GLP-1 guides.
Why "safely" matters so much with these medicines
GLP-1 medicines have transformed weight management. In the SURMOUNT-1 trial, people taking tirzepatide 15mg lost an average of about 21% of their body weight over 72 weeks, compared with about 3% on placebo. In STEP 1, semaglutide 2.4mg produced average weight loss of about 15% over 68 weeks, compared with about 2% on placebo. Results vary a lot between individuals, and these figures come from trials that included diet and activity support.
Those results have created huge demand, and with it a market for fake, unlicensed and poorly supervised products. The risks fall into three groups:
- Product risk: counterfeit or unlicensed injections that may contain the wrong substance, the wrong dose, or contaminants, or may not be sterile.
- Prescribing risk: genuine medicine prescribed to someone for whom it is unsafe, such as a person with a history of pancreatitis, an eating disorder, or a pregnancy.
- Use risk: incorrect dosing, poor storage, or not recognising warning symptoms at home.
A safe route protects against all three.
The legal framework in brief
In the UK:
- Mounjaro, Wegovy and other GLP-1 medicines are prescription-only medicines (POMs). They can only be supplied against a valid prescription.
- Pharmacies in Great Britain must be registered with the General Pharmaceutical Council (GPhC). In Northern Ireland, the regulator is the Pharmaceutical Society of Northern Ireland (PSNI).
- Prescribers must be registered with their professional regulator: the GMC (doctors), GPhC (pharmacist prescribers) or NMC (nurse prescribers).
- Online doctor services in England providing regulated activities must be registered with the Care Quality Commission (CQC), with equivalent regulators in Wales, Scotland and Northern Ireland.
- The MHRA regulates medicines and their supply chain, and investigates illegal sales.
- Advertising prescription-only medicines to the public is illegal. The Advertising Standards Authority (ASA) has acted against weight-loss medicine adverts.
For a full explanation, see our guide to who regulates online weight loss services.
Step 1: Choose a regulated service
What to check on the website
A legitimate online pharmacy should display, typically in its footer or regulatory information page:
- The registered pharmacy name and address
- Its GPhC registration number
- The superintendent pharmacist's name
- Company details
- Information about who prescribes (and their registration)
Check the registers independently
Go to the regulator's website yourself, rather than clicking a link on the pharmacy's site:
| What to check | Where | What to confirm |
|---|---|---|
| The pharmacy | GPhC register of pharmacies (Great Britain) or PSNI register (Northern Ireland) | Listed, current, address matches |
| The superintendent pharmacist | GPhC register of pharmacists | Registered |
| Doctors | GMC register | Registered with a licence to practise |
| Nurse prescribers | NMC register | Registered with a prescribing qualification |
| Online doctor service (England) | CQC website | Registered; read any inspection report |
Some pharmacies display a voluntary GPhC logo, but logos can be copied. Checking the register directly is more reliable. Our guide to how to choose an online pharmacy for weight loss treatment gives a full checklist.
Step 2: Expect a proper consultation
A safe service treats the consultation as a clinical assessment. You should expect:
- Identity checks, such as an electronic ID check or photo ID
- Independent weight verification. Since February 2025, GPhC guidance has said that prescribing weight-loss medicines should not rely on an online questionnaire alone, and weight, height or BMI should be verified independently, for example by video consultation or GP records.
- Detailed medical questions about weight-related conditions, medicines, allergies, pregnancy and contraception, and history of pancreatitis, gallbladder disease, eating disorders and thyroid cancer
- A request to share information with your GP
- A starting dose in line with the licence, normally the lowest dose (2.5mg Mounjaro or 0.25mg Wegovy)
Our guides to the online weight loss consultation and why online pharmacies verify your ID and weight explain what is asked and why. It is important to answer honestly. Our guide to who should not take GLP-1 medicines explains why each question matters.
Step 3: Make sure the medicine is genuine
What licensed medicine looks like
Genuine Mounjaro in the UK is supplied as the KwikPen, a multi-dose pre-filled pen, according to the UK SmPC at the time of writing. Genuine Wegovy injection is supplied as the FlexTouch pen. Both come in branded outer packaging with a patient information leaflet, batch number and expiry date, and the pharmacy dispensing label should show your name, the medicine, dose and instructions.
Warning signs of a fake or unlicensed product
- Vials of powder that you are told to mix ("reconstitute") yourself
- Products labelled "for research use only" or "not for human consumption"
- Unbranded pens, or pens with misspelled or poor-quality labels
- Packaging in a language other than English with no UK leaflet
- Products described as "generic tirzepatide", "compounded semaglutide" or under invented brand names
- Retatrutide or other medicines not licensed in the UK at the time of writing
- Unusually low prices or bulk deals
The MHRA's Criminal Enforcement Unit has seized large quantities of unlicensed weight-loss injections. In October 2025 it reported what it described as the largest seizure of its kind, at a facility producing unlicensed tirzepatide and retatrutide pens. Our guide to fake and unlicensed weight loss jabs covers this in detail.
Step 4: Where not to get weight loss injections
The following are not legal or safe sources of prescription-only weight-loss medicines:
- Social media sellers (Instagram, TikTok, Facebook, Snapchat and similar)
- Messaging apps such as WhatsApp or Telegram
- Beauty salons, aesthetics clinics without a registered prescriber, gyms or personal trainers
- Friends, family or colleagues sharing their medicine
- Websites that do not display registered pharmacy details
- Overseas websites shipping prescription-only medicines without a UK prescription
- "Peptide" or "research chemical" websites
Even if the product happens to be genuine, using medicine prescribed for someone else, or without any assessment, removes every safety check.
Step 5: Using your injections safely at home
Once you have a legitimate prescription, safe use at home matters just as much.
Injecting correctly
- Read the patient information leaflet and instructions for use for your pen.
- Inject once weekly, on the same day each week, into the abdomen, thigh or upper arm, rotating sites.
- Use a new needle each time and never share pens or needles.
- Ask your pharmacy for a demonstration or video guidance if you are unsure.
Our guides to injecting with the Mounjaro KwikPen and using the Wegovy pen walk through each step.
Dose increases
Both medicines start at a low dose and increase gradually, usually every four weeks, to reduce side effects. Never increase your dose yourself, and never "catch up" on a missed dose by doubling. The SmPCs give specific missed-dose rules: for Mounjaro, a missed dose can be taken within four days; for Wegovy, within five days. Outside these windows, skip the dose and continue as normal. See our guide to what to do if you miss a Mounjaro dose.
| Medicine | Starting dose | Typical step-up | Maintenance options |
|---|---|---|---|
| Mounjaro (tirzepatide) | 2.5mg weekly | Increase by 2.5mg at least every 4 weeks, if needed and tolerated | 5mg to 15mg weekly |
| Wegovy (semaglutide) | 0.25mg weekly | 0.5mg, 1mg, 1.7mg, then 2.4mg at 4-weekly intervals | 2.4mg weekly; up to 7.2mg for some adults with obesity (approved by the MHRA in January 2026; check the current SmPC) |
Your prescriber will decide the right schedule for you.
Storage
Unused pens should be kept in the fridge (2°C to 8°C) and not frozen. The SmPCs allow limited time out of the fridge at room temperature. Check your leaflet for the exact conditions. See our guide to storage and travel.
Sharps disposal
Used needles should go into a sharps bin, not household waste. Ask your pharmacy or local council about collection and disposal.
Step 6: Know the side effects and red flags
Common side effects include nausea, diarrhoea, constipation, vomiting, indigestion and tiredness, particularly when starting or increasing the dose. These often settle. Our guide to nausea on GLP-1 medicines has practical tips.
Less common but serious problems include pancreatitis, gallbladder disease, dehydration leading to kidney problems, and severe allergic reactions. GLP-1 medicines also slow stomach emptying, which matters before surgery or sedation. The red-flag symptoms are listed in the final section of this guide.
The first weeks of treatment: what to expect
Knowing what is normal in the early weeks helps you tell the difference between expected adjustment and something that needs attention.
Week 1 to 4: the starting dose
The starting dose (2.5mg Mounjaro or 0.25mg Wegovy) is designed mainly to let your body get used to the medicine, rather than to produce large weight loss. Many people notice reduced appetite and feeling full sooner. Nausea, mild indigestion, constipation or loose stools are common, and often settle within days of each injection.
Dose increases
Side effects can return or increase for a few days after each dose step. Your prescriber should check in before each increase. If side effects are difficult, it is reasonable to ask whether you can stay on your current dose for longer. Not everyone needs, or tolerates, the highest dose.
Eating and drinking
Eating smaller portions, eating slowly, and stopping when you feel full can reduce nausea. Focusing on protein, vegetables and fluids helps protect muscle and prevent dehydration. Our guides to what to eat on GLP-1 medicines and hydration on GLP-1 medicines have practical suggestions.
Tracking progress
Weight loss is usually gradual, and early changes can vary from week to week. Our guide to realistic weight loss expectations explains what the trials suggest about typical patterns over time.
Travelling with weight loss injections
If you travel during treatment:
- Keep pens in your hand luggage, not in the hold, where they could freeze.
- Carry them in their original packaging with the pharmacy label.
- Take a copy of your prescription or a letter from your prescriber, particularly for international travel. Rules on carrying medicines vary by country, so check before you go.
- Plan for storage at your destination, and check the leaflet for how long pens can be kept out of the fridge.
- Think about time zones when planning your weekly injection day.
Our guide to Mounjaro storage and travel covers this in more detail.
Common mistakes to avoid
- Increasing the dose yourself because weight loss has slowed. This increases side effects and removes the prescriber's oversight.
- Doubling up after a missed dose. Follow the missed-dose rules in your leaflet instead.
- Restarting at a high dose after a break. After several missed weeks, ask your prescriber whether you need to restart lower.
- Using two GLP-1 medicines at once, for example a weight-loss injection alongside Ozempic or Rybelsus.
- Holding prescriptions from two services at the same time.
- Ignoring persistent symptoms, especially severe abdominal pain or signs of dehydration.
- Forgetting to mention your injections before surgery, sedation or an endoscopy.
- Sharing pens, even with a new needle. Pens are for one person only.
Step 7: Keep your GP in the loop
Tell your GP you are taking a GLP-1 medicine, or give your online service consent to do so. This matters because:
- Your GP needs an accurate medicines record
- Some medicines, including insulin and sulfonylureas, may need adjusting
- Surgical, anaesthetic and endoscopy teams need to know (the MHRA has highlighted the risk of pulmonary aspiration during anaesthesia or deep sedation)
- Your GP can help with side effects or further assessment
Understanding the costs safely
The costs of private treatment vary with the medicine, dose, and what is included, such as consultations, needles and delivery. Prices can change: Lilly raised the UK list price of Mounjaro from September 2025, for example. We don't quote prices in our guides. You can compare current service costs and what is included on our prices page.
Be cautious of unusually low prices, "flash sales" or bulk discounts. Prescription-only medicines must not be promoted to the public, and price that seems too good to be true can indicate a fake or unlicensed product.
Comparing regulated services
Our providers page explains how we compare regulated services on safety, consultation process and transparency, rather than on promotional claims. You can also compare two services side by side using our compare tool.
A quick safety checklist
- The pharmacy is on the GPhC or PSNI register, and its details match the website
- The prescriber is named and registered
- There is a real consultation with identity and weight checks
- The medicine is a licensed, branded product with a UK leaflet and pharmacy label
- You start at the licensed starting dose
- You know how to inject, store and dispose of your pens
- You know the red-flag symptoms
- Your GP is informed
If you can't tick all of these, pause and seek advice before going further.
Other routes to treatment
The NHS offers GLP-1 treatment to people who meet NICE criteria. Tirzepatide is being rolled out in phases through primary care in England, starting with people with the highest clinical need, and semaglutide is available through specialist weight management services. Access is limited and varies by area. See our guide to private vs NHS weight loss treatment. You might also consider whether a face-to-face option suits you better: see weight loss clinics vs online providers.
When to speak to a professional
Speak to your GP or a pharmacist before starting if you have other health conditions, take regular medicines, are planning a pregnancy, or are unsure whether a service is legitimate. The decision to prescribe always rests with a qualified prescriber.
If you are taking a weight loss injection:
- Call 999 or go to A&E if you have severe, persistent abdominal pain (with or without vomiting, sometimes spreading to your back), signs of a serious allergic reaction such as swelling of the face, lips, tongue or throat or difficulty breathing, or you collapse.
- Contact NHS 111 or your GP urgently if you have persistent vomiting or diarrhoea with signs of dehydration (dark urine, dizziness, passing very little urine), pain under the right ribs with fever or yellowing of the skin or eyes, or symptoms of low blood sugar if you have diabetes.
- Stop and seek advice if you suspect your product is fake or has been tampered with, and report it to the MHRA through the Yellow Card scheme.
- Contact your prescriber if you become pregnant, are planning surgery or sedation, or notice changes in your mood. If you have thoughts of self-harm, call 999 or Samaritans on 116 123.
Frequently asked questions
Sources
- Guidance for registered pharmacies providing pharmacy services at a distance, including on the internet. General Pharmaceutical Council, 2025.
- Mounjaro KwikPen: Summary of Product Characteristics. Electronic medicines compendium (emc), 2026.
- Wegovy FlexTouch: Summary of Product Characteristics. Electronic medicines compendium (emc), 2026.
- Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). New England Journal of Medicine, 2022.
- Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). New England Journal of Medicine, 2021.
- Yellow Card: report a suspected side effect or fake medicine. Medicines and Healthcare products Regulatory Agency, 2026.
- MHRA smashes major illicit weight-loss medicine production facility in record seizure. Medicines and Healthcare products Regulatory Agency, 2025.
- Tirzepatide for managing overweight and obesity (TA1026). National Institute for Health and Care Excellence, 2024.
Written by
Our editorial team researches UK weight management medicines and regulated online providers, working from primary sources such as SmPCs, NICE guidance and peer-reviewed trials.
This article has not yet been reviewed by a registered clinician. Read our editorial policy to see how clinical review works.
Related guides
Safety Fake and Unlicensed Weight Loss Jabs: How to Spot Them
How to spot fake Mounjaro, counterfeit Wegovy and unlicensed weight loss jabs in the UK, the health risks involved, and what to do if you have used one.
13 min read
Choosing a provider How to Choose an Online Pharmacy for Weight Loss Treatment
A practical checklist for choosing a UK online pharmacy for weight loss treatment: registration checks, clinical safeguards, aftercare and clear costs.
12 min read
Choosing a provider GPhC, CQC and MHRA: Who Regulates Online Weight Loss Services?
How UK online pharmacies and online doctors offering weight loss treatment are regulated by the GPhC, CQC, MHRA, GMC, NMC and ASA, and how to check them.
12 min read